CN1051317C - 用置换色谱纯化血红蛋白产物的方法 - Google Patents

用置换色谱纯化血红蛋白产物的方法 Download PDF

Info

Publication number
CN1051317C
CN1051317C CN94190708A CN94190708A CN1051317C CN 1051317 C CN1051317 C CN 1051317C CN 94190708 A CN94190708 A CN 94190708A CN 94190708 A CN94190708 A CN 94190708A CN 1051317 C CN1051317 C CN 1051317C
Authority
CN
China
Prior art keywords
hemoglobin
column
solution
hbao
impurities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94190708A
Other languages
English (en)
Chinese (zh)
Other versions
CN1114836A (zh
Inventor
D·朴陆拉
D·威芬
S·阿史拉福
A·A·马格因
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hemosol Inc
Original Assignee
Hemosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemosol Inc filed Critical Hemosol Inc
Priority claimed from ZA951034A external-priority patent/ZA951034B/xx
Publication of CN1114836A publication Critical patent/CN1114836A/zh
Application granted granted Critical
Publication of CN1051317C publication Critical patent/CN1051317C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/42—Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/422—Displacement mode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN94190708A 1993-09-21 1994-09-20 用置换色谱纯化血红蛋白产物的方法 Expired - Fee Related CN1051317C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2,106,612 1993-09-21
CA002106612A CA2106612C (en) 1993-09-21 1993-09-21 Displacement chromatography process
ZA951034A ZA951034B (en) 1993-09-21 1995-02-09 Displacements chromatography process and purified hemoglobin product

Publications (2)

Publication Number Publication Date
CN1114836A CN1114836A (zh) 1996-01-10
CN1051317C true CN1051317C (zh) 2000-04-12

Family

ID=25676656

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94190708A Expired - Fee Related CN1051317C (zh) 1993-09-21 1994-09-20 用置换色谱纯化血红蛋白产物的方法

Country Status (9)

Country Link
US (1) US5439591A (enExample)
EP (1) EP0668877B1 (enExample)
CN (1) CN1051317C (enExample)
AU (1) AU681438B2 (enExample)
CA (1) CA2106612C (enExample)
CZ (1) CZ287589B6 (enExample)
PL (1) PL179525B1 (enExample)
SK (1) SK281839B6 (enExample)
WO (1) WO1995008574A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545328A (en) * 1993-09-21 1996-08-13 Hemosol Inc. Purification of hemoglobin by displacement chromatography
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
WO1998008537A1 (en) * 1996-08-27 1998-03-05 Hemosol Inc. Enhanced stimulation of erythropoiesis
US6054427A (en) * 1997-02-28 2000-04-25 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US5851400A (en) * 1997-03-21 1998-12-22 University Of Maryland At Baltimore County Method for eliminating the displacer in displacement chromatography of proteins
US6423233B1 (en) * 2000-08-15 2002-07-23 Biogal Gyogyszergyar Rt. Purification process
GB9707696D0 (en) * 1997-04-16 1997-06-04 Agner Erik Improvements in or relating to chromatography
US6239262B1 (en) 1998-01-07 2001-05-29 Rensselaer Polytechnic Institute Low molecular weight displacers for protein purification in hydrophobic interaction and reversed phase chromatographic systems
CA2233725A1 (en) * 1998-03-31 1999-09-30 Hemosol Inc. Hemoglobin-hydroxyethyl starch complexes
GB9822963D0 (en) * 1998-10-20 1998-12-16 Agner Erik Improvements in or relating to chromatography
US6573373B1 (en) 1999-06-29 2003-06-03 Isis Pharmaceuticals, Inc. High affinity, low molecular weight displacers for oligonucleotide purification
US6747132B2 (en) 2000-11-29 2004-06-08 Apex Biosciences, Inc. Methods for the synthesis of a modified hemoglobin solution
US7195923B2 (en) * 2001-01-31 2007-03-27 Scripps Laboratories, Inc. Ratiometric determination of glycated protein
ES2545526T3 (es) * 2001-02-01 2015-09-11 Sigma-Aldrich Co. Llc Matrices de afinidad mejorada con visibilidad mejorada para aplicaciones de arrastre molecular e inmunoprecipitación
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US6929747B2 (en) 2002-02-28 2005-08-16 Renesselaer Polytechnic Institute High-affinity, low-molecular-mass displacers for ion-exchange chromatography
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
BRPI0608584B8 (pt) 2005-03-11 2021-05-25 Wyeth Corp métodos de recuperar um produto purificado
DE112006001012B4 (de) * 2005-04-22 2017-05-18 Waters Technologies Corp. (N.D.Ges.D. Staates Delaware) Verfahren für eine auf Massenspektrometrie gerichtete Aufbereitung von Biopolymeren
CA2630806C (en) * 2005-12-02 2015-01-06 Sachem, Inc. Anion-exchange displacement chromatography process and anionic organic compounds for use as displacer compounds in anion-exchange displacement chromatography process
US7976708B2 (en) * 2008-05-12 2011-07-12 Secretary, Department of Atormic Energy Innovative cut-and-feed operation for enhancing the performance of ion-exchange chromatographic separation
HUE066562T2 (hu) 2008-08-14 2024-08-28 Genentech Inc Eljárások szennyezés eltávolítására indigén fehérje kiszorításos ioncserés membrán kromatográfia alkalmazásával
EP4786482A2 (en) 2009-08-06 2026-08-05 F. Hoffmann-La Roche AG Virus filtration methods
US8304248B2 (en) 2009-11-16 2012-11-06 Torres Anthony R Protein separation via ion-exchange chromatography and associated methods, systems, and devices
HRP20171095T4 (hr) * 2010-05-25 2022-07-22 F. Hoffmann - La Roche Ag Postupci pročišćavanja polipeptida
JP2014503495A (ja) 2010-11-15 2014-02-13 バイオジェン アイデック インコーポレイテッド 過負荷結合および溶出クロマトグラフィによる選択生成物アイソフォームの富化および濃縮
US8293115B2 (en) * 2011-01-20 2012-10-23 Gordon Rossiter Ionic impurities rejection and chromatographic purification using ion exchange
GB201103363D0 (en) * 2011-02-28 2011-04-13 Ge Healthcare Uk Ltd Sample preservation method and sample application substrate
KR20140091721A (ko) * 2011-11-02 2014-07-22 제넨테크, 인크. 오버로드 및 용리 크로마토그래피
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
CN103665098B (zh) * 2012-09-20 2015-08-05 中国科学院大连化学物理研究所 双相柱膜蛋白质微反应器及其应用
DK2994485T3 (en) 2013-05-06 2018-04-23 Sanofi Sa CONTINUOUS MULTIPLE STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
JP6600123B1 (ja) * 2018-04-18 2019-10-30 積水メディカル株式会社 ヘモグロビン分析方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925574A (en) * 1985-06-26 1990-05-15 Canadian Patents & Development Limited Purification of hemoglobin and modified hemoglobin by affinity chromatography
US5028696A (en) * 1988-10-28 1991-07-02 Torres Anthony R Ion exchange and separation method
US5115100A (en) * 1988-08-17 1992-05-19 Kinetic Investments Limited Purification of hemoglobin and methemoglobin by bioselective elution

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971842A (en) * 1974-08-08 1976-07-27 Atlantic Richfield Company Continuous displacement chromatographic separation
FR2548670B1 (fr) * 1983-07-07 1985-10-25 Merieux Inst Procede de preparation des principales proteines du sang hemolyse sous forme non denaturee
JPS6075530A (ja) * 1983-09-30 1985-04-27 Asahi Chem Ind Co Ltd 金属元素の新しい分離精製方法
US5084558A (en) * 1987-10-13 1992-01-28 Biopure Corporation Extra pure semi-synthetic blood substitute
US5340474A (en) * 1988-03-24 1994-08-23 Terrapin Technologies, Inc. Panels of analyte-binding ligands
US5149436A (en) * 1988-11-28 1992-09-22 Union Oil Company Of California Continuous displacement chromatographic method
IT1232311B (it) * 1989-09-04 1992-01-28 Sclavo Spa Metodo di purificazione di composti a struttura peptidica o pseudo peptidica a basso peso molecolare.
US5264555A (en) * 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925574A (en) * 1985-06-26 1990-05-15 Canadian Patents & Development Limited Purification of hemoglobin and modified hemoglobin by affinity chromatography
US5115100A (en) * 1988-08-17 1992-05-19 Kinetic Investments Limited Purification of hemoglobin and methemoglobin by bioselective elution
US5028696A (en) * 1988-10-28 1991-07-02 Torres Anthony R Ion exchange and separation method

Also Published As

Publication number Publication date
SK67895A3 (enExample) 1995-09-13
WO1995008574A1 (en) 1995-03-30
CZ128795A3 (en) 1995-12-13
SK281839B6 (sk) 2001-08-06
PL309034A1 (en) 1995-09-18
EP0668877A1 (en) 1995-08-30
AU681438B2 (en) 1997-08-28
CA2106612A1 (en) 1995-03-22
PL179525B1 (pl) 2000-09-29
CA2106612C (en) 2001-02-06
CN1114836A (zh) 1996-01-10
EP0668877B1 (en) 1999-01-20
CZ287589B6 (en) 2000-12-13
AU7650394A (en) 1995-04-10
US5439591A (en) 1995-08-08

Similar Documents

Publication Publication Date Title
CN1114836A (zh) 置换色谱方法及纯化的血红蛋白产物
AU718557B2 (en) A method for chromatographic removal of prions
JP6148673B2 (ja) β‐β架橋を容易にする熱安定性酸素担体含有組成物の調製方法
JPH04504720A (ja) タンパク質精製のための方法
US5545328A (en) Purification of hemoglobin by displacement chromatography
CN101035439A (zh) 通过亲和色谱法进行的连续蛋白质分离和提纯方案
CN101730707A (zh) 使用混合式或多模式树脂来纯化因子ⅷ
AU2009270723A1 (en) Method of preparing alpha-1 proteinase inhibitor
JP4250769B2 (ja) 高度に精製されたｖＷＦまたは因子ＶＩＩＩ／ｖＷＦ複合体を得る方法
US20240025950A1 (en) Method of purification of recombinantly-produced rsv proteins in trimeric form
EP2640413B1 (en) A process for reduction and/or removal of fxi and fxia from solutions containing said coagulation factors
JPS63503352A (ja) タンパク質の精製
CN103153333B (zh) 补体因子h的纯化方法
KR19990087623A (ko) 셀룰로스계 여과 보조제를 이용한 혈장 혼합물의 여과
JP4057049B2 (ja) 置換クロマトグラフィー法および精製ヘモグロビン産物
EP4188414A1 (en) Improvements to wash solutions for anion exchange chromatography in a method of purification of recombinantly-produced rsv proteins
EP0555135B1 (fr) Procédé de fabrication de fibrinogène de très haute pureté
HAMOGLOBIN et al. EUROPEAN PATENT SPECIFICATION
JPS5810522A (ja) 不活化トロンビンゲルによるアンチトロンビン３の精製法
HUE025551T2 (en) A method of producing virus-inactivated FV concentrate starting from human plasma, which can be increased to industrial sizes

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20000412

Termination date: 20091020